Differential Delivery of Follow-up Care and Survivorship Among Latinos Using Medi
Differential Delivery of Follow-up Care and Survivorship Among Latinos Using Medi
批准号:
7992991
负责人:
Julie Smith-Gagen
金额:
$8.13万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-15 至 2012-06-30
关键词:
AddressAgeAreaBreastCancer SurvivorCaringCessation of lifeClinicalCommunitiesCommunity HealthCommunity HealthcareData LinkagesData SetDiagnosisDiseaseEducational BackgroundEthnic groupHealthHealth PersonnelHealth Services ResearchHealth behaviorHealthcareHealthcare SystemsHispanicsInterventionInvestigationKnowledgeLatinaLatinoLifeLow incomeMalignant NeoplasmsMedical SurveillanceMedicareNeighborhoodsNot Hispanic or LatinoOccupationsOutcomePoliciesPolicy MakerPopulationProstateQuality of CareRaceReportingResearchResearch InfrastructureResearch PersonnelRiskRisk FactorsScientistSocietiesStagingSupportive careTrainingWomancancer carecancer therapycare deliverycomparative effectivenesseffectiveness researchevidence basefollow-upgraduate studenthealth care deliveryinnovationmalignant breast neoplasmmalignant stomach neoplasmpublic health relevancestandard caresurveillance datasurvivorship
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Differential Delivery of Follow-up Care and Survivorship Among Latinos Using Medicare This application addresses broad Challenge Area (05) Comparative Effectiveness Research and specific Challenge Topic, 05-AA-101 Innovative Analyses of Existing Clinical Datasets. Research shows equal access to cancer treatment and supportive care eliminates disparities in outcomes. Latinos comprise 45.5 million people in the US. Although many reports demonstrate Latinos, compared to non-Hispanics, have lower risks of some diseases and death and even have better health behaviors despite having traditional risk factors associated with poor health such as low income and education levels. Paradoxally, Latinos with some cancers are more likely to die sooner than non-Latinos. For example, a Latina woman diagnosed with breast cancer is 22% more likely to die of breast cancer during the 5 years after diagnosis than a non- Latina white woman of the same age with the same stage of disease. This phenomena needs urgent investigation. The reasons for poorer survival in the Latino community are unclear but may reflect poorer access to timely, high quality treatment. Scientists have not studied if the timeliness of cancer and preventative care that Latinos with breast, prostate and stomach cancers receive impacts their survivorship. This study will focus on the Surveillance, Epidemiology, and End Results (SEER) cancer surveillance data linkage to Medicare. First, this study will assess how soon after a diagnosis Latinos receive standard care for breast, prostate and stomach cancers compared to other ethnic groups. Then this study will determine if delays in either cancer care or general preventative health care depends on where Latinos live (i.e. neighborhoods that are poor, without many doctors or where most residents speak only Spanish). Finally, this study will assess if the delays in treatment and care are associated with earlier death in Latinos compared to other ethnic groups. By the end of the 2-year study period, this study will have trained graduate students in health services research providing infrastructure to address the most challenging questions in health care delivery. Society will know barriers that stand in the way of timely and high-quality care for Latino cancer survivors. This research will assist policy makers, the research community and the health care system apply current knowledge about successful treatments equally throughout the population and ultimately reduce disparities between ethnic and racial groups and develop effective targeted interventions and policies to avoid one-size-fits-all policies that perpetuate disparities in cancer survival.
PUBLIC HEALTH RELEVANCE: This project will provide knowledge about the differential delivery of follow-up care and its impact on survivorship in the Latino population. Policy makers, the research community, and health providers will use this knowledge to provide evidence based delivery of care equally throughout the population. This project provides graduate students and disparities researchers' jobs and provides the infrastructure to reduce disparities in ethnic groups adversely impacted by the recession.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differential Delivery of Follow-up Care and Survivorship Among Latinos Using Medi
-
批准号:8107507
-
项目类别:
-
资助金额:$7.51万
-
财政年份:2010
-
负责人:Julie Smith-Gagen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: